Edition:
United States

GTX Inc (GTXI.OQ)

GTXI.OQ on NASDAQ Stock Exchange Capital Market

5.67USD
26 Jul 2017
Change (% chg)

-- (--)
Prev Close
$5.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,172
52-wk High
$11.10
52-wk Low
$2.77

Latest Key Developments (Source: Significant Developments)

GTX qtrly loss per share $0.04
Tuesday, 9 Aug 2016 07:00am EDT 

Gtx Inc : Gtx provides corporate update and reports second quarter 2016 financial results .Qtrly loss per share $0.04.  Full Article

GTx reports Q1 earnings per share $0.01
Tuesday, 10 May 2016 07:00am EDT 

GTx Inc : GTx provides corporate update and reports first quarter 2016 financial results . Qtrly earnings per share $0.01 .Q1 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S.  Full Article

GTx, Inc receives FDA clearance to initiate clinical trial in Stress Urinary Incontinence
Tuesday, 13 Oct 2015 07:00am EDT 

GTx, Inc:Receives FDA clearance to initiate clinical trial in stress urinary incontinence.Says trial to evaluate an orally administered sarm in postmenopausal women with stress urinary incontinence.Says preclinical data demonstrates a sarm can increase pelvic floor muscle mass and potentially improve outcomes in women with sui.Says company plans to initiate the trial by the first quarter of 2016 and anticipates top-line data later in 2016.Says FDA has accepted the company's investigational new drug (ind) application for a phase 2 clinical trial.  Full Article

BRIEF-GTX announces positive preliminary results from ongoing trial in women with stress urinary incontinence

* GTX announces positive preliminary results from ongoing phase 2 proof-of-concept clinical trial in women with stress urinary incontinence